Dr. William John Dahms , DO
Internal Medicine - Nephrology โข Newark, DE
4923 Ogletown Stanton Rd, Suite 200
Newark, DE 197132081
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. William Dahms is listed in NPPES under Internal Medicine - Nephrology.
-
NPI assigned on August 26, 2006; this date does not establish years in practice.
-
Published CMS data list 4,215 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- Q5106 โ Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units: 900 service units.
- Q9967 โ Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml: 875 service units.
- 99233 โ Subsequent hospital care with moderate levelof medical decision making: 527 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 21 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 1,158 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Torsemide โ 248 prescription fills, including refills.
- Losartan Potassium โ 153 prescription fills, including refills.
- Allopurinol โ 89 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 30 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 80% of clinicians listed under Internal Medicine - Nephrology in Newark, DE (2024, 17 clinicians with data). Median for this group: 3,672. Middle half: 1,322 to 3,999.
More Medicare Part B services than 75% of clinicians listed under Internal Medicine - Nephrology in Delaware (2024, 38 clinicians with data). Median for this group: 2,846. Middle half: 1,371 to 3,981.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 6,574 in 2020 to 4,215 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
4923 Ogletown Stanton Rd
Suite 200
Newark, DE 197132081
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Nephrology Associates Pa. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Philadelphia College Of Osteopathic Medicine
2000
What Public CMS Data Show
Internal Medicine - Nephrology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
691 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $320,315 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $249,891 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
3,155 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$300,926 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $2,656.14 across 109 records.
By nature of payment
- Food and Beverage: $2,618.60 across 107 records.
- Education: $37.54 across 2 records.
Reporting-company totals (3 largest of 24)
- Ardelyx, Inc.: $277.92 across 11 records.
- Amgen Inc.: $269.13 across 14 records.
- Calliditas Therapeutics US Inc.: $262.29 across 9 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
26 years (graduated 2000)
CMS Doctors and Clinicians data list 2000 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Dahms has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Dahms as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Newark and Delaware
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 80% of clinicians listed under Internal Medicine - Nephrology in Newark, DE (2024, 17 clinicians with data). Median for this group: 3,672. Middle half: 1,322 to 3,999.
More Medicare Part B services than 75% of clinicians listed under Internal Medicine - Nephrology in Delaware (2024, 38 clinicians with data). Median for this group: 2,846. Middle half: 1,371 to 3,981.
Medicare-allowed amount
A higher Medicare-allowed amount than 75% of clinicians listed under Internal Medicine - Nephrology in Newark, DE (2024, 17 clinicians with data). Median for this group: $233,255. Middle half: $151,849 to $320,315.
A higher Medicare-allowed amount than 75% of clinicians listed under Internal Medicine - Nephrology in Delaware (2024, 38 clinicians with data). Median for this group: $225,307. Middle half: $168,394 to $316,063.
Paid by Medicare
A higher Medicare payment amount than 75% of clinicians listed under Internal Medicine - Nephrology in Newark, DE (2024, 17 clinicians with data). Median for this group: $180,676. Middle half: $116,220 to $249,891.
A higher Medicare payment amount than 75% of clinicians listed under Internal Medicine - Nephrology in Delaware (2024, 38 clinicians with data). Median for this group: $175,600. Middle half: $132,145 to $245,684.
Medicare Part D prescriptions
More Part D prescriptions than 75% of clinicians listed under Internal Medicine - Nephrology in Newark, DE (2024, 17 clinicians with data). Median for this group: 819. Middle half: 428 to 1,158.
More Part D prescriptions than 75% of clinicians listed under Internal Medicine - Nephrology in Delaware (2024, 40 clinicians with data). Median for this group: 836. Middle half: 471 to 1,139.
Part D drug cost
A higher Part D drug cost than 80% of clinicians listed under Internal Medicine - Nephrology in Newark, DE (2024, 17 clinicians with data). Median for this group: $80,962. Middle half: $53,704 to $266,466.
A higher Part D drug cost than 70% of clinicians listed under Internal Medicine - Nephrology in Delaware (2024, 40 clinicians with data). Median for this group: $141,395. Middle half: $43,047 to $305,235.
22 active clinicians are listed under Internal Medicine - Nephrology with a practice address in Newark, DE (52 in Delaware).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Newark
63.6% of these 22 clinicians have the CMS telehealth indicator.
77.3% of these 22 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 36% from 6,574 in 2020 to 4,215 in 2024.
- 2020: 6,574
- 2021: 5,166
- 2022: 5,339
- 2023: 4,350
- 2024: 4,215
-
Medicare-allowed amount
Medicare-allowed amount decreased 38% from $513,855 in 2020 to $320,315 in 2024.
- 2020: $513,855
- 2021: $408,239
- 2022: $367,775
- 2023: $347,204
- 2024: $320,315
-
Paid by Medicare
Paid by Medicare decreased 38% from $405,591 in 2020 to $249,891 in 2024.
- 2020: $405,591
- 2021: $323,696
- 2022: $290,348
- 2023: $273,717
- 2024: $249,891
-
Medicare Part D prescriptions
Medicare Part D prescriptions stayed about the same: 1,060 in 2020 and 1,158 in 2024.
- 2020: 1,060
- 2021: 1,044
- 2022: 1,119
- 2023: 1,093
- 2024: 1,158
-
30-day fills
30-day fills increased 16% from 2,730 in 2020 to 3,155 in 2024.
- 2020: 2,730
- 2021: 2,783
- 2022: 2,942
- 2023: 2,917
- 2024: 3,155
-
Part D drug cost
Part D drug cost increased 213% from $96,039 in 2020 to $300,926 in 2024.
- 2020: $96,039
- 2021: $46,974
- 2022: $77,797
- 2023: $128,466
- 2024: $300,926
-
Industry payments (Open Payments)
Industry payments (Open Payments) decreased 68% from $8,199.66 in 2021 to $2,656.14 in 2025.
- 2021: $8,199.66
- 2022: $32,952.52
- 2023: $19,342.76
- 2024: $1,954.48
- 2025: $2,656.14
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 109 records totaling $2,656.14.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Eli Lilly and Company |
Food and Beverage
Cash or cash equivalent
|
ZEPBOUND | General | $121.25 |
| Vifor Pharma, Inc. |
Food and Beverage
In-kind items and services
|
Veltassa | General | $101.52 |
| Ardelyx, Inc. |
Food and Beverage
In-kind items and services
|
XPHOZAH 30 MG | General | $86.50 |
| Calliditas Therapeutics US Inc. |
Food and Beverage
In-kind items and services
|
TARPEYO | General | $74.41 |
| Mallinckrodt Hospital Products Inc. |
Food and Beverage
In-kind items and services
|
ACTHAR | General | $38.20 |
| Mallinckrodt Hospital Products Inc. |
Food and Beverage
In-kind items and services
|
ACTHAR | General | $35.85 |
| Mallinckrodt Hospital Products Inc. |
Food and Beverage
In-kind items and services
|
ACTHAR | General | $35.44 |
| Calliditas Therapeutics US Inc. |
Food and Beverage
In-kind items and services
|
TARPEYO | General | $34.40 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. |
Food and Beverage
In-kind items and services
|
โ | General | $33.23 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
Vanrafia | General | $33.20 |
| Otsuka America Pharmaceutical, Inc. |
Food and Beverage
In-kind items and services
|
VOYXACT | General | $32.76 |
| Calliditas Therapeutics US Inc. |
Food and Beverage
In-kind items and services
|
TARPEYO | General | $32.22 |
| AstraZeneca Pharmaceuticals LP |
Food and Beverage
In-kind items and services
|
FARXIGA | General | $31.89 |
| Mallinckrodt Hospital Products Inc. |
Food and Beverage
In-kind items and services
|
ACTHAR | General | $30.09 |
| Fresenius USA Marketing, Inc. |
Food and Beverage
In-kind items and services
|
VELPHORO | General | $29.03 |
| ANI Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
PURIFIED CORTROPHIN GEL | General | $28.90 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
Fabhalta | General | $28.67 |
| Fresenius USA Marketing, Inc. |
Food and Beverage
In-kind items and services
|
VELPHORO | General | $28.32 |
| ANI Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
PURIFIED CORTROPHIN GEL | General | $28.29 |
| ANI Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
PURIFIED CORTROPHIN GEL | General | $27.89 |
| Ardelyx, Inc. |
Food and Beverage
In-kind items and services
|
IBSRELA | General | $27.88 |
| Aurinia Pharma U.S., Inc. |
Food and Beverage
In-kind items and services
|
LUPKYNIS | General | $27.83 |
| Aurinia Pharma U.S., Inc. |
Food and Beverage
In-kind items and services
|
LUPKYNIS | General | $27.81 |
| AKEBIA THERAPEUTICS INC |
Food and Beverage
In-kind items and services
|
Vafseo | General | $27.37 |
| Fresenius USA Marketing, Inc. |
Food and Beverage
In-kind items and services
|
VELPHORO | General | $27.12 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2017โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
Q5106
Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units
|
900 | 35 | $10.00 | $7.34 |
|
Q9967
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml
|
875 | 26 | $0.25 | $0.13 |
|
99233
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
|
527 | 198 | $126.94 | $115.24 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
366 | 247 | $20.00 | $16.01 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
340 | 232 | $170.00 | $104.21 |
|
90960
Dialysis services, 4 or more physician visits per month (20 years or older)
|
291 | 40 | $660.00 | $342.92 |
|
99232
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes
|
271 | 117 | $92.44 | $76.43 |
|
90935
Hemodialysis procedure with physician evaluation
|
144 | 84 | $325.00 | $68.54 |
|
99223
Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes
|
117 | 111 | $260.00 | $168.35 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
73 | 48 | $235.00 | $114.50 |
|
96372
Injection of drug or substance under skin or into muscle
|
52 | 35 | $30.00 | $14.00 |
|
90966
Home dialysis services per month (20 years or older)
|
49 | 11 | $660.00 | $285.14 |
|
77001
Fluoroscopic guidance for insertion or removal of central vein access device
|
42 | 38 | $35.00 | $17.31 |
|
36558
Insertion of tunneled central venous tube for infusion (5 years or older)
|
40 | 36 | $750.00 | $236.13 |
|
76937
Ultrasonic guidance for blood vessel access
|
37 | 34 | $30.00 | $13.39 |
|
90961
Dialysis services, 2-3 physician visits per month (20 years or older)
|
28 | 14 | $604.00 | $284.60 |
|
99291
Critical care, first 30-74 minutes
|
17 | 13 | $380.00 | $206.75 |
|
36902
Insertion of needle and/or tube into hemodialysis circuit and balloon dilation of dialysis segment with review by radiologist
|
12 | 11 | $1900.00 | $1151.43 |
|
99153
Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes
|
12 | 11 | $20.00 | $11.33 |
|
99152
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes
|
11 | 11 | $80.00 | $49.09 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
11 | 11 | $225.00 | $163.73 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Torsemide | Torsemide | 248 | 20,936 | $4,040.55 | 77 |
| Losartan Potassium | Losartan Potassium | 153 | 13,382 | $1,764.24 | 48 |
| Allopurinol | Allopurinol | 89 | 7,969 | $985.65 | 28 |
| Amlodipine Besylate | Amlodipine Besylate | 61 | 5,490 | $524.15 | 21 |
| Spironolactone | Spironolactone | 56 | 4,920 | $843.85 | 20 |
| Chlorthalidone | Chlorthalidone | 46 | 4,140 | $782.49 | 14 |
| Eplerenone | Eplerenone | 42 | 2,453 | $3,421.50 | 11 |
| Furosemide | Furosemide | 40 | 3,123 | $274.29 | 12 |
| Hydralazine Hcl | Hydralazine Hcl | 32 | 2,920 | $341.34 | 12 |
| Potassium Citrate Er | Potassium Citrate | 32 | 2,700 | $2,371.82 | 13 |
| Carvedilol | Carvedilol | 29 | 2,650 | $217.30 | โ |
| Lisinopril | Lisinopril | 28 | 2,520 | $251.97 | โ |
| Tamsulosin Hcl | Tamsulosin Hcl | 28 | 2,280 | $406.02 | 11 |
| Hydrochlorothiazide | Hydrochlorothiazide | 25 | 1,830 | $66.53 | โ |
| Metoprolol Succinate | Metoprolol Succinate | 24 | 2,160 | $545.49 | โ |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 22 | 1,376 | $306.14 | โ |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 19 | 1,650 | $222.36 | โ |
| Metoprolol Tartrate | Metoprolol Tartrate | 17 | 1,530 | $158.69 | โ |
| Atorvastatin Calcium | Atorvastatin Calcium | 17 | 1,463 | $470.75 | โ |
| Mirtazapine | Mirtazapine | 17 | 510 | $162.03 | โ |
| Jardiance | Empagliflozin | 17 | 1,350 | $26,312.42 | โ |
| Kerendia | Finerenone | 16 | 1,200 | $24,109.49 | โ |
| Bumetanide | Bumetanide | 14 | 1,200 | $105.42 | โ |
| Sevelamer Carbonate | Sevelamer Carbonate | 14 | 540 | $2,024.78 | โ |
| Lokelma | Sodium Zirconium Cyclosilicate | 14 | 540 | $14,240.14 | โ |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2021-06-17NUCC Taxonomy Code: 207RN0300X
An internist who treats disorders of the kidney, high blood pressure, fluid and mineral balance and dialysis of body wastes when the kidneys do not function. This specialist consults with surgeons about kidney transplantation.
NUCC Taxonomy Code: 207RN0300X
An internist who treats disorders of the kidney, high blood pressure, fluid and mineral balance and dialysis of body wastes when the kidneys do not function. This specialist consults with surgeons about kidney transplantation.
Additional State Medicaid & Healthcare Payer Identifiers
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - NEPHROLOGY
I20080822000054
DE
4981606274
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Nephrology Associates Pa
137 W High St, Elkton, MD 219218614
Phone: 4106209200
Nephrology Associates Pa
4923 Ogletown Stanton Rd, Newark, DE 197132081
Phone: 3022250451
Nephrology Associates Pa
701 N Clayton St, Wilmington, DE 198053165
Phone: 3024219411
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner
Nurse Practitioner
Internal Medicine - Nephrology
Doctor of Medicine (M.D.)
Internal Medicine - Nephrology
Doctor of Medicine (M.D.)
Internal Medicine - Nephrology
Doctor of Medicine (M.D.)
Internal Medicine - Nephrology
Doctor of Osteopathic Medicine (D.O.)
Internal Medicine - Nephrology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Internal Medicine (license number reported to NPPES: DE C2-0008640)
NPI status registered as active in NPPES database
Registered at 4923 OGLETOWN STANTON RD, SUITE 200, NEWARK, DE 197132081 (Tel: 3022250451)
Registered at 4923 OGLETOWN STANTON RD, SUITE 200, NEWARK, DE 197132081 (Tel: 3022250451)
Recorded as WILLIAM DAHMS, D.O.
Internal Medicine (license number reported to NPPES: DE C2-0008640)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine - Nephrology Specialists in Newark
- Dr. James Torain, MD
- Dr. Jeffrey Cicone, MD
- Dr. Carlos Machado, MD
- Dr. Nealanjon Das, DO
- Dr. Prayus Tailor, MD
- Dr. Farhana Chowdhury, MD
Mailing Address
4923 Ogletown Stanton Rd, Suite 200
Newark, DE 197132081
Phone: 3022250451